Ozkardesler S.Gurpinar T.Akan M.Koca U.Sarikaya H.Olmez T.Elar Z.2024-07-222024-07-22200809528180http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/18995Serotonin syndrome occurs with selective serotonin reuptake inhibitors, opioids, and other serotonergic agents. We describe a possible serotonin syndrome related to intrathecal fentanyl in a patient taking multiple drugs and substances such as ergot alkaloids, marijuana, methylenedioxy-N-methylamphetamine, and ephedrine. © 2008 Elsevier Inc. All rights reserved.EnglishAdultAnalgesics, OpioidEphedrineErgot AlkaloidsFentanylHumansInjections, SpinalMaleMarijuana SmokingN-Methyl-3,4-methylenedioxyamphetamineSerotonin SyndromeSubstance-Related DisordersTreatment Outcome3,4 methylenedioxyamphetaminebupivacainecannabisdexamethasonediphenhydramineephedrineergot alkaloidfentanylmidazolammorphinepropofoltenoxicamvecuroniumacute appendicitisadultarticleauditory hallucinationcase reportdrug dose increasedrug hypersensitivityerythemageneral anesthesiahospitalizationhouse dust allergyhumanlaboratory testleukocytosismalemigrainepostoperative analgesiapriority journalserotonin syndromespinal anesthesiavisual hallucinationA possible perianesthetic serotonin syndrome related to intrathecal fentanylArticle10.1016/j.jclinane.2007.06.024